ArticleBlood science (Baltimore, Md.)2026
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy.
Hao Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.